Survey: Payers, Providers Boosting IT Investments
Bain & Co./KLAS Research survey finds 75% of providers and payers have increased IT investments
Read More
Teens, Drugs, and Overdose: Contrasting Pre-Pandemic and Current Trends
This brief analyzes the latest CDC data on adolescent overdose deaths, finding that from 2022 to 2023, there was a small reduction in overdose fatalities among adolescents (from 721 to 708 deaths). Additionally, the synthetic opioid, fentanyl, has largely driven the increase in adolescent drug fatalities since the pandemic began, accounting for 76% of these…
Startup Crystalys Therapeutics Emerges With $205M to Fill a Growing Gap in Gout Treatment
Crystalys Therapeutics’ gout drug, dotinurad, inhibits a known and validated target for treating the chronic disorder, but in a way that could be safer than other drugs. The oral small molecule was discovered and developed in Japan, where it is approved and has a safety record spanning more than 1 million gout patients. The post…
Watch: Why Insurance Companies Are Denying Coverage for Prosthetic Limbs
PBS News Weekend’s Ali Rogin spoke with KFF Health News contributor Michelle Andrews about what some people with missing limbs consider a disparity in health insurance coverage: Though a knee replacement likely would be covered, a prosthetic knee isn’t always. A prosthetic device can be subject to cost caps and an amputee may be required…
As Trump Denies Climate Change, At Least 170 Hospitals Face Major Flood Risk
In West Virginia’s capital of Charleston, where about 50,000 people live in a wide, flat river valley, an intense storm has the potential to flood five of the city’s six hospitals at once. At the largest hospital, as much as 5 feet of water could reach the emergency room. At the children’s hospital, the river…
AI-Designed Insilico Drug Flashes Signs of Efficacy in Lung Disease, But Rivals Are Still Ahead
Insilico Medicine’s idiopathic pulmonary fibrosis drug led to dose-dependent improvement in lung function in a mid-stage study. Meanwhile, Pliant Therapeutics and PureTech Health are also making Phase 2 progress while Boehringer Ingelheim is planning regulatory submission supported by its IPF drug’s Phase 3 data. The post AI-Designed Insilico Drug Flashes Signs of Efficacy in Lung…
Headway Launches Enhanced EHR Platform for Mental Health Providers
Headway has expanded its EHR system to include an AI-assisted notes feature and an integrated telehealth capability. The post Headway Launches Enhanced EHR Platform for Mental Health Providers appeared first on MedCity News.
Readers Speak Up for Patients Who Can’t, and for Kids With Disabilities
Letters to the Editor is a periodic feature. We welcome all comments and will publish a selection. We edit for length and clarity and require full names. A reporter at Just the News shared our article about a man whose organs were nearly harvested while he was still alive: Disinformed consent is standard operating procedure in the organ…
A Look at the Potential Impact of the High Unemployment Hardship Exception to Medicaid Work Requirements
This issue brief describes the hardship exception for individuals living in counties with high unemployment, and using the most recent available county-level unemployment data, estimates the number of counties that could meet the criteria for this exception and the number of expansion enrollees living in those counties who could be exempt from work requirements.
Considering Covering GLP-1s? Here’s What You Need to Know
Though chronic disease treatment is rapidly expanding, balancing the latest medication with proven initiatives can help employers manage rising healthcare costs wherever you fall on the GLP-1 coverage spectrum. The post Considering Covering GLP-1s? Here’s What You Need to Know appeared first on MedCity News.